Similar articles for PMID: 20153925

Year	Number of Results
1997	1
2000	1
2002	7
2003	10
2004	8
2005	8
2006	11
2007	8
2008	10
2009	9
2010	15
2011	16
2012	13
2013	12
2014	9
2015	20
2016	11
2017	5
2018	5
2019	4
2020	2
2021	6
2022	2
2023	3
2024	0

1

MYCN oncoprotein targets and their therapeutic potential.

Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA. Bell E, et al. Cancer Lett. 2010 Jul 28;293(2):144-57. doi: 10.1016/j.canlet.2010.01.015. Epub 2010 Feb 13. Cancer Lett. 2010. PMID: 20153925 Review.

2

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM. Wang Q, et al. Cancer Res. 2003 Apr 1;63(7):1631-5. Cancer Res. 2003. PMID: 12670915

3

ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.

Vandesompele J, Edsjö A, De Preter K, Axelson H, Speleman F, Påhlman S. Vandesompele J, et al. Oncogene. 2003 Jan 23;22(3):456-60. doi: 10.1038/sj.onc.1206148. Oncogene. 2003. PMID: 12545167

4

MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.

Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH. Kang JH, et al. Biochem Biophys Res Commun. 2006 Dec 8;351(1):192-7. doi: 10.1016/j.bbrc.2006.10.020. Epub 2006 Oct 12. Biochem Biophys Res Commun. 2006. PMID: 17055458 Free PMC article.

5

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M. Westermann F, et al. Genome Biol. 2008 Oct 13;9(10):R150. doi: 10.1186/gb-2008-9-10-r150. Genome Biol. 2008. PMID: 18851746 Free PMC article.

6

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Chen Y, Stallings RL. Chen Y, et al. Cancer Res. 2007 Feb 1;67(3):976-83. doi: 10.1158/0008-5472.CAN-06-3667. Cancer Res. 2007. PMID: 17283129

7

Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.

Veas-Perez de Tudela M, Delgado-Esteban M, Cuende J, Bolaños JP, Almeida A. Veas-Perez de Tudela M, et al. J Neurochem. 2010 May;113(4):819-25. doi: 10.1111/j.1471-4159.2010.06648.x. Epub 2010 Feb 17. J Neurochem. 2010. PMID: 20180881 Free article.

8

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.

Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C. Buechner J, et al. Differentiation. 2011 Jan;81(1):25-34. doi: 10.1016/j.diff.2010.09.184. Epub 2010 Oct 25. Differentiation. 2011. PMID: 20980091

9

p53 is a direct transcriptional target of MYCN in neuroblastoma.

Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA. Chen L, et al. Cancer Res. 2010 Feb 15;70(4):1377-88. doi: 10.1158/0008-5472.CAN-09-2598. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145147 Free PMC article.

10

TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.

Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S. Selmi A, et al. Cancer Lett. 2015 Feb 1;357(1):412-418. doi: 10.1016/j.canlet.2014.11.056. Epub 2014 Dec 1. Cancer Lett. 2015. PMID: 25475555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

176 results

Results by year